SCHEMBL6837356

SCHEMBL6837356

COc1ccc(Cn2cc3c(n2)CC(F)Cc2sc(Nc4nccc(C)n4)nc2-3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 3/20 0.39
GRM8 O00222 1/20 0.35
AADAT Q8N5Z0 1/20 0.33
ACHE P22303 5/20 0.33
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
THRB P10828 1/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 2/20 0.32
ALDH1A1 P00352 2/20 0.32
SYK P43405 1/20 0.32
PSMD14 O00487 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
CCNK O75909 1/20 0.32
CDK12 Q9NYV4 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369801 0.91 GRM4 (0.40) GRM4GRM8AADATACHENPC1
SCHEMBL369405 0.91 GRM4 (0.40) GRM4GRM8AADATACHENPC1
SCHEMBL367983 0.87 GRM4 (0.49) GRM4GRM8ACHENPC1PKM
SCHEMBL369301 0.86 GRM4 (0.39) GRM4GRM8ACHENPC1PKM
SCHEMBL370838 0.85 GRM4 (0.35) GRM4GRM8AADATACHETHRB
SCHEMBL15260933 0.83 GRM4 (0.39) GRM4GRM8AADATACHENPC1
SCHEMBL370384 0.82 GRM4 (0.43) GRM4GRM8ACHENPC1PKM
SCHEMBL365918 0.82 GRM4 (0.43) GRM4GRM8AADATACHENPC1
SCHEMBL6837269 0.81 GRM4 (0.37) GRM4GRM8AADATACHENPC1
SCHEMBL370071 0.81 GRM4 (0.44) GRM4GRM8NPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012008999-A2 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed
WO-2012006760-A1 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. GRM3, GRM6, GRM1 GRM4 7/4885GRM8 4/4885AADAT 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.